Brian Thompson Shooting Linked To UnitedHealthcare’s ‘Stock Selling Scheme?

The CEO of UnitedHealthcare, Brian Thompson, was shot and killed in Manhattan on Wednesday in an apparent targeted attack, several news websites reported, citing law enforcement sources. The unidentified gunman remains on the loose. The 50-year-old executive was walking toward the New York Hilton Hotel when a armed white male fired at him, hitting him on his chest, reports added.

Following the incident, several social media users speculate if the shooting was linked to UnitedHealth‘s apparent stock selling scheme. Earlier this year, Bloomberg reported that the group’s chairman, Stephen Hemsley, and three senior executives netted a combined $101.5 million from sales of company stock over four months before a federal investigation into the company’s practices became public knowledge. The company has been under scrutiny since.

These stock sales, which occurred in 2023 and earlier, have raised concerns about potential insider trading. The Justice Department is reportedly investigating UnitedHealth’s practices related to its Medicare Advantage business, including whether the company overstated patient illnesses to increase payouts.

However, authorities have not commented on the potential link between Thompson’s death and stock selling. “Could the murder of UnitedHealthcare CEO Brian Thompson be connected to his stock selling scheme while they were under investigation by the DOJ for antitrust laws?” one person said on X, platform formerly known as Twitter.

“Brian Thompson and United Healthcare were being investigated by the DOJ for violating anti trust laws and were also being sued for not disclosing the investigation to investors before the media reported on it causing investors to lose millions of dollars,” another person added.